Skip to main content

Table 1 Baseline characteristics of the whole real-world dataset of elderly NPC patients

From: Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study

Characteristics

No. patients, N = 1714 (%)

Gender

 Male

1302 (76.0)

 Female

412 (24.0)

Age at diagnosis (years)

 60–64

878 (51.2)

 65–69

545 (31.8)

   ≥ 70

291 (17.0)

Histological type

 WHO type I–II

38 (2.2)

 WHO type III

1676 (97.8)

Family history of cancer

 No

1254 (73.2)

 Yes

460 (26.8)

ACE-27 (scores)

 0

835 (48.7)

 1

741 (43.2)

 2

138 (8.1)

Plasma EBV DNA titer (copy/mL)

  ≤ 4000

1053 (61.4)

  > 4000

661 (38.6)

T category

 T1

186 (10.9)

 T2

253 (14.8)

 T3

854 (49.8)

 T4

421 (24.6)

N category

 N0

315 (18.4)

 N1

748 (43.6)

 N2

434 (25.3)

 N3

217 (12.7)

Stage

 I

77 (4.5)

 II

242 (14.1)

 III

803 (46.9)

 IV

592 (34.5)

Treatment

 IC + CCRT

460 (26.8) 

 CCRT

632 (36.9)

 IC + RT

171 (10.0)

 RT alone

451 (26.3)

  1. Stage, T category and N category were determined based on the 8th edition of American Joint Committee on Cancer/International Union Against Cancer staging system
  2. Plasma EBV DNA plasma Epstein–Barr Virus DNA, NPC nasopharyngeal carcinoma, WHO World Health Organization, CCRT concurrent chemoradiotherapy, IC induction chemotherapy, RT radiotherapy